Literature DB >> 32557523

Phosphorylated TDP-43 localizes to chronic cerebral infarctions in human brains.

Takahiko Umahara1,2, Toshiki Uchihara3, Kentaro Hirao2, Soichiro Shimizu2, Haruo Hanyu2.   

Abstract

The transactivation response DNA-binding protein of 43 kDa (TDP-43) is a nuclear protein pivotal in RNA processing. Because phosphorylated TDP43 (pTDP-43) has been identified as a component of the ubiquitin-positive and tau-negative inclusions observed in the brains of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS) patients, it is considered to play a major role in neurodegenerative processes. We previously reported that pTDP-43 is located in macrophages of atherosclerotic lesions of human carotid and major cerebral arteries. We hence hypothesized that pTDP-43 might be localized in the macrophages of other human brain lesions. Therefore, we investigated the immunolocalization of pTDP-43 in human brains with chronic cerebral infarction. Furthermore, we investigated the colocalization of pTDP-43 and the 14-3-3 eta isoform and found that pTDP-43 was localized in many macrophages located in chronic cerebral infarctions, in 6 out of the 15 human brains analyzed. pTDP-43 colocalized with the 14-3-3 eta isoform in these lesions. This is the first demonstration of pTDP-43 immunolocalization in chronic cerebral infarctions in human brains. We believe that our findings may be useful towards further understanding the pathophysiological roles of TDP-43 in various neurological disorders.

Entities:  

Year:  2020        PMID: 32557523     DOI: 10.14670/HH-18-235

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  16 in total

Review 1.  14-3-3 proteins: a historic overview.

Authors:  Alastair Aitken
Journal:  Semin Cancer Biol       Date:  2006-04-01       Impact factor: 15.707

2.  Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis.

Authors:  Johannes Brettschneider; David J Libon; Jon B Toledo; Sharon X Xie; Leo McCluskey; Lauren Elman; Felix Geser; Virginia M Y Lee; Murray Grossman; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2012-01-01       Impact factor: 17.088

3.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

4.  Biochemical and histopathological alterations in TAR DNA-binding protein-43 after acute ischemic stroke in rats.

Authors:  Masato Kanazawa; Akiyoshi Kakita; Hironaka Igarashi; Tetsuya Takahashi; Kunio Kawamura; Hitoshi Takahashi; Tsutomu Nakada; Masatoyo Nishizawa; Takayoshi Shimohata
Journal:  J Neurochem       Date:  2011-03       Impact factor: 5.372

5.  Ferritin immunohistochemistry as a marker for microglia.

Authors:  Y Kaneko; T Kitamoto; J Tateishi; K Yamaguchi
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Tetsuaki Arai; Masato Hasegawa; Haruhiko Akiyama; Kenji Ikeda; Takashi Nonaka; Hiroshi Mori; David Mann; Kuniaki Tsuchiya; Mari Yoshida; Yoshio Hashizume; Tatsuro Oda
Journal:  Biochem Biophys Res Commun       Date:  2006-10-30       Impact factor: 3.575

7.  Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Masato Hasegawa; Tetsuaki Arai; Takashi Nonaka; Fuyuki Kametani; Mari Yoshida; Yoshio Hashizume; Thomas G Beach; Emanuele Buratti; Francisco Baralle; Mitsuya Morita; Imaharu Nakano; Tatsuro Oda; Kuniaki Tsuchiya; Haruhiko Akiyama
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

8.  TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system.

Authors:  Edward B Lee; Virginia M-Y Lee; John Q Trojanowski; Manuela Neumann
Journal:  Acta Neuropathol       Date:  2007-12-18       Impact factor: 17.088

Review 9.  Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72.

Authors:  Mauricio Budini; Emanuele Buratti; Eugenia Morselli; Alfredo Criollo
Journal:  Front Mol Neurosci       Date:  2017-05-30       Impact factor: 5.639

10.  Subarachnoid hemorrhage enhances the expression of TDP-43 in the brain of experimental rats and human subjects.

Authors:  Tibiao He; Yuchun Zuo; Kauthar Ai-Zakwani; Jing Luo; Haixia Zhu; Xiao-Xin Yan; Fei Liu
Journal:  Exp Ther Med       Date:  2018-08-21       Impact factor: 2.447

View more
  1 in total

1.  Dynamic Changes in Central and Peripheral Neuro-Injury vs. Neuroprotective Serum Markers in COVID-19 Are Modulated by Different Types of Anti-Viral Treatments but Do Not Affect the Incidence of Late and Early Strokes.

Authors:  Krzysztof Laudanski; Jihane Hajj; Mariana Restrepo; Kumal Siddiq; Tony Okeke; Daniel J Rader
Journal:  Biomedicines       Date:  2021-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.